Summary
Lili Du is a research scientist combining a medical background with advanced biostatistics and pharmacology expertise to drive translational cancer research. Based in Houston, she currently coordinates collaborative molecular pathology projects at MD Anderson Cancer Center, leveraging nine years of study design, large-data analytics, and predictive modeling using both internal and public datasets. Her work spans RNA-based clinical assays for therapy response in breast cancer, exploration of JNK isoforms in skin cancer, and leadership in multidisciplinary research teams. She is proficient in Excel, R, SAS, STATA, Linux, and SQL, with working knowledge of Python and HPC-based data management, and has extensive experience with clinical trials and observational studies. With a PhD in Pharmacology, an MS in Biostatistics, and an MBBS, she uniquely blends clinical insight with quantitative rigor to turn complex data into actionable medical insights.
10 years of coding experience
Doctor of Philosophy (Ph.D.), Pharmacology, Doctor of Philosophy (Ph.D.), Pharmacology at Medical College of Wisconsin
MS, Oncology, MS, Oncology at Nanjing University
Master's degree, Biostatistics, Master's degree, Biostatistics at The University of Texas Health Science Center at Houston (UTHealth Houston)
MBBS, Medicine, MBBS, Medicine at Jiangsu University
English, Chinese